INCYTE CORPORATION Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)
INCYTE CORPORATION (INCY) reported Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) of $12.00 million for the 12-month period ending 2017-12-31, per its 10-K filed 2020-02-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill · last filed 2020-02-13
- INCYTE CORPORATION impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2017-12-31 was $0.00.
- INCYTE CORPORATION impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2017-09-30 was $12.00M.
- INCYTE CORPORATION impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2017 was $12.00M.
| Period end | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 3 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 6 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 9 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $12.00M derived: sum of 2 quarters · filed 2020-02-13 | $12.00M 10-K · filed 2020-02-13 | |
| 2017-09-30 | $12.00M 10-K · filed 2019-02-14 | $12.00M 10-Q · filed 2018-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |